Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05466981 · ClinicalTrials.gov registry record · NA
HCV-Smoking Cessation Study
A NA study of Smoking Cessation and Hepatitis C, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05466981 is a NA study of Smoking Cessation and Hepatitis C that has completed, run by Prisma Health-Upstate. The registered enrollment target is 10 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05466981, a NA study of Smoking Cessation and Hepatitis C, has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
A 12-week study for patients who are being treated for Hepatitis C and would like to quit smoking. During the 12 weeks of Hepatitis C treatment, the research team will have counseling sessions with the participants to discuss challenges related to Hepatitis C and smoking.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Counseling
Study Locations (1)
South Carolina
- Prisma Health Internal Medicine Clinic - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-11-23 |
| Est. Completion | 2021-11-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05466981
The ClinicalTrials.gov registry entry for NCT05466981 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (98% lower). The listed sponsor is Prisma Health-Upstate, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Counseling is the first listed.
NCT05466981 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT05466981 about?
NCT05466981 is a clinical study titled "HCV-Smoking Cessation Study". A 12-week study for patients who are being treated for Hepatitis C and would like to quit smoking. During the 12 weeks of Hepatitis C treatment, the research team will have counseling sessions with the participants to discuss challenges related to Hepatitis C and smoking.
What is the current status of trial NCT05466981?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2020-11-23. Estimated completion is 2021-11-11.
What conditions does trial NCT05466981 study?
This clinical trial studies the following conditions: Smoking Cessation, Hepatitis C.
What interventions are being tested in trial NCT05466981?
The interventions under investigation include: Cognitive Behavioral Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT05466981?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05466981 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.